This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...

| Real-world evidence lets us see how HIV medicines work in real life, helping HCPs provide better care and improving ...

LEN is a first-in-class, long-acting HIV-1 capsid inhibitor that disrupts multiple stages of the viral replication cycle. By ...

North America was the major shareholder in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period. PO ...

By Albert Allotey Accra, GNA-The JANOK Foundation, a non-governmental organization at Laterbiokorshie in Accra has ...

HIV-positive mothers with undetectable viral load can now safely breastfeed their infants, according to recently updated ...

The Association of Government Information Officers in Region 8 (AGIO-8), led by its president, lawyer Jonalyndie B. Chua ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

This year’s Conference on Retroviruses and Opportunistic Infections (CROI) features several sessions discussing prevention ...

More than half of the people living with HIV in Philadelphia are 50 and older, and they face greater risk of frailty and impairment.